Does the fetal genotype affect maternal physiology during pregnancy?

Trends in Molecular Medicine

Volumn 13, Issue 10, 2007, Pages 414-421

  Petry, Clive J ^a   Ong, Ken K ^a,b   Dunger, David B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BECKWITH WIEDEMANN SYNDROME; FEMALE; FETUS; FETUS GROWTH; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MATERNAL DISEASE; MATERNAL HYPERTENSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS;

ANIMALS; BECKWITH-WIEDEMANN SYNDROME; FEMALE; FETAL DEVELOPMENT; GENOTYPE; HUMANS; MATERNAL-FETAL EXCHANGE; MICE; MODELS, BIOLOGICAL; PREGNANCY;

MUS;

EID: 35248837822     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2007.07.007     Document Type: Article

References (68)

1. Basoglu O.K. The oral glucose tolerance test in patients with respiratory infections. Monaldi Arch. Chest Dis. 54 (1999) 307-310
2. Cross J.C. How to make a placenta: mechanisms of trophoblast cell differentiation in mice - a review. Placenta 26 Suppl. A (2005) S3-S9
3. Wangler M.F., et al. Factors associated with preterm delivery in mothers of children with Beckwith-Wiedemann syndrome: a case cohort study from the BWS registry. Am. J. Med. Genet. A. 134 (2005) 187-191
4. Kanayama N., et al. Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol. Hum. Reprod. 8 (2002) 1129-1135
5. Hanson M., and Gluckman P. Endothelial dysfunction and cardiovascular disease: the role of predictive adaptive responses. Heart 91 (2005) 864-866
6. Graafmans W.C., et al. Birth weight and perinatal mortality: a comparison of "optimal" birth weight in seven Western European countries. Epidemiology 13 (2002) 569-574
7. Naeye R.L. Maternal blood pressure and fetal growth. Am. J. Obstet. Gynecol. 141 (1981) 780-787
8. Ong K.K., et al. Size at birth and early childhood growth in relation to maternal smoking, parity and infant breast-feeding: longitudinal birth cohort study and analysis. Pediatr. Res. 52 (2002) 863-867
9. Ounsted M., et al. Constrained and unconstrained fetal growth: associations with some biological and pathological factors. Ann. Hum. Biol. 15 (1988) 119-129
10. Catalano P.M., et al. Phenotype of infants of mothers with gestational diabetes. Diabetes Care 30 Suppl. 2 (2007) S156-S160
11. Sosenko I.R., et al. The infant of the diabetic mother: correlation of increased cord C-peptide levels with macrosomia and hypoglycemia. N. Engl. J. Med. 301 (1979) 859-862
12. Jacquemyn Y., et al. Preeclampsia and birth weight by gestational age in singleton pregnancies in Flanders, Belgium: a prospective study. Clin. Exp. Obstet. Gynecol. 33 (2006) 96-98
13. Lindsay R.S., et al. Secular trends in birth weight, BMI, and diabetes in the offspring of diabetic mothers. Diabetes Care 23 (2000) 1249-1254
14. Pouta A., et al. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension 43 (2004) 825-831
15. Barker D.J., et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36 (1993) 62-67
16. Hales C.N., et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303 (1991) 1019-1022
17. Barker D.J., et al. Fetal and placental size and risk of hypertension in adult life. BMJ 301 (1990) 259-262
18. Breschi M.C., et al. Relation of birth weight to maternal plasma glucose and insulin concentrations during normal pregnancy. Diabetologia 36 (1993) 1315-1321
19. Watanabe R.M., et al. Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes and interacts with adiposity to alter insulin secretion in Mexican Americans. Diabetes 56 (2007) 256-264
20. Bryson C.L., et al. Association between gestational diabetes and pregnancy-induced hypertension. Am. J. Epidemiol. 158 (2003) 1148-1153
21. Ceesay S.M., et al. Effects on birth weight and perinatal mortality of maternal dietary supplements in rural Gambia: 5 year randomised controlled trial. BMJ 315 (1997) 786-790
22. Buchanan T.A., and Kitzmiller J.L. Metabolic interactions of diabetes and pregnancy. Annu. Rev. Med. 45 (1994) 245-260
23. Johns K., et al. Gestational diabetes mellitus outcome in 394 patients. J. Obstet. Gynaecol. Can. 28 (2006) 122-127
24. Dunger D.B., et al. Genetics of size at birth. Diabetes Care 30 Suppl. 2 (2007) S150-S155
25. Haig D. Genetic conflicts in human pregnancy. Q. Rev. Biol. 68 (1993) 495-532
26. Merviel P., et al. Correlations between serum assays of human chorionic gonadotrophin (hCG) and human placental lactogen (hPL) and pre-eclampsia or intrauterine growth restriction (IUGR) among nulliparas younger than 38 years. Eur. J. Obstet. Gynecol. Reprod. Biol. 95 (2001) 59-67
27. Sorensen S., et al. Serial measurements of serum human placental lactogen (hPL) and serial ultrasound examinations in the evaluation of fetal growth. Early Hum. Dev. 60 (2000) 25-34
28. Mahajan S.D., et al. Effect of maternal malnutrition and anemia on the endocrine regulation of fetal growth. Endocr. Res. 30 (2004) 189-203
29. Konchak P.S., et al. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels. Am. J. Obstet. Gynecol. 173 (1995) 1115-1119
30. Kim C., et al. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care 25 (2002) 1862-1868
31. Cross J.C. The genetics of pre-eclampsia: a feto-placental or maternal problem?. Clin. Genet. 64 (2003) 96-103
32. Buchanan T.A., et al. What is gestational diabetes?. Diabetes Care 30 Suppl. 2 (2007) S105-S111
33. Baker P.N., et al. Platelet angiotensin II binding and plasma renin concentration, plasma renin substrate and plasma angiotensin II in human pregnancy. Clin. Sci. (Lond.) 79 (1990) 403-408
34. Sweeney M., et al. Ultrastructural features of smooth muscle and endothelial cells of isolated isobaric human placental and maternal arteries. Placenta 27 (2006) 635-647
35. Norwitz E.R., et al. Maternal physiology and complications of multiple pregnancy. Semin. Perinatol. 29 (2005) 338-348
36. Dekker G.A., and Robillard P.Y. Preeclampsia: a couple's disease with maternal and fetal manifestations. Curr. Pharm. Des. 11 (2005) 699-710
37. Tamimi R.M., et al. Average energy intake among pregnant women carrying a boy compared with a girl. BMJ 326 (2003) 1245-1246
38. Takahashi K., et al. Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation. J. Biochem. (Tokyo) 127 (2000) 73-83
39. Rijhsinghani A., et al. Risk of preeclampsia in second-trimester triploid pregnancies. Obstet. Gynecol. 90 (1997) 884-888
40. Takimoto E., et al. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 274 (1996) 995-998
41. Haig D., and Westoby M. Parent-specific gene expression and the triploid endosperm. Am. Nat. 134 (1989) 147-155
42. Haig D. Genomic imprinting and the theory of parent-offspring conflict. Semin. Dev. Biol. 3 (1992) 153-160
43. Innes K.E., et al. Association of a woman's own birth weight with her subsequent risk for pregnancy-induced hypertension. Am. J. Epidemiol. 158 (2003) 861-870
44. Innes K.E., et al. Association of a woman's own birth weight with subsequent risk for gestational diabetes. J. Am. Med. Assoc. 287 (2002) 2534-2541
45. Petry C.J., et al. Common polymorphism in H19 associated with birth weight and cord blood IGF-II levels in humans. BMC Genet. 6 (2005) 22
46. Casteels K., et al. Mitochondrial 16189 variant, thinness at birth and type 2 diabetes. Lancet 353 (1999) 1499-1500
47. Barlow D.P., et al. The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus. Nature 349 (1991) 84-87
48. DeChiara T.M., et al. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64 (1991) 849-859
49. Wang Z.Q., et al. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372 (1994) 464-467
50. Ong K., et al. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. J. Clin. Endocrinol. Metab. 85 (2000) 4266-4269
51. DeChiara T.M., et al. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345 (1990) 78-80
52. Constancia M., et al. Placental-specific IGF-II is a major modulator of placental and fetal growth. Nature 417 (2002) 945-948
53. Moore T., et al. Multiple imprinted sense and antisense transcripts, differential methylation and tandem repeats in a putative imprinting control region upstream of mouse Igf2. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 12509-12514
54. Leighton P.A., et al. Disruption of imprinting caused by deletion of the H19 gene region in mice. Nature 375 (1995) 34-39
55. Reik W., et al. Regulation of supply and demand for maternal nutrients in mammals by imprinted genes. J. Physiol. 547 (2003) 35-44
56. Sibley C.P., et al. Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 8204-8208
57. Constancia M., et al. Adaptation of nutrient supply to fetal demand in the mouse involves interaction between the Igf2 gene and placental transporter systems. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 19219-19224
58. Biensen N.J., et al. The impact of either a Meishan or Yorkshire uterus on Meishan or Yorkshire fetal and placental development to days 70, 90 and 110 of gestation. J. Anim. Sci. 76 (1998) 2169-2176
59. Wilson M.E., et al. Development of Meishan and Yorkshire littermate conceptuses in either a Meishan or Yorkshire uterine environment to day 90 of gestation and to term. Biol. Reprod. 58 (1998) 905-910
60. Allen W.R., et al. The influence of maternal size on placental, fetal and postnatal growth in the horse. II. Endocrinology of pregnancy. J. Endocrinol. 172 (2002) 237-246
61. Allen W.R., et al. Influence of maternal size on placental, fetal and postnatal growth in the horse. I. Development in utero. Reproduction 123 (2002) 445-453
62. Rebarber A., et al. Increased incidence of gestational diabetes in women receiving prophylactic 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery. Diabetes Care 30 (2007) 2277-2280
63. Skjaerven R., et al. The interval between pregnancies and the risk of preeclampsia. N. Engl. J. Med. 346 (2002) 33-38
64. Saftlas A.F., and Levine R.J. The interval between pregnancies and preeclampsia. N. Engl. J. Med. 346 (2002) 1831-1832
65. O'Brien T.E., et al. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 14 (2003) 368-374
66. Bodnar L.M., et al. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology 18 (2007) 234-239
67. Wild S., et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004) 1047-1053
68. Fetita L.S., et al. Consequences of fetal exposure to maternal diabetes in offspring. J. Clin. Endocrinol. Metab. 91 (2006) 3718-3724